The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis

被引:96
作者
Bae, Jong Seok [1 ,2 ]
Simon, Neil G. [2 ]
Menon, Parvathi [2 ,3 ]
Vucic, Steve [2 ,3 ]
Kiernan, Matthew C. [2 ,4 ]
机构
[1] Inje Univ, Coll Med, Dept Neurol, Pusan, South Korea
[2] Neurosci Res Australia, Sydney, NSW, Australia
[3] Univ Sydney, Westmead Clin Sch, Dept Neurol, Westmead, NSW 2145, Australia
[4] Univ New S Wales, Prince Wales Clin Sch, Multidisciplihary Motor Neurone Dis Clin Serv, Sydney, NSW, Australia
来源
JOURNAL OF CLINICAL NEUROLOGY | 2013年 / 9卷 / 02期
关键词
amyotrophic lateral sclerosis; hyperexcitability; corticomotoneuron; interneuron; gamma-aminobutyric acid; MOTOR-NEURON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; FRONTOTEMPORAL LOBAR DEGENERATION; AXONAL EXCITABILITY PROPERTIES; THRESHOLD TRACKING TECHNIQUES; DISSOCIATED SMALL HAND; CORTICAL HYPEREXCITABILITY; SPLIT HAND; FASCICULATION POTENTIALS; CORTEX INHIBITION;
D O I
10.3988/jcn.2013.9.2.65
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The development of hyperexcitability in amyotrophic lateral sclerosis (ALS) is a well-known phenomenon. Despite controversy as to the underlying mechanisms, cortical hyperexcitability appears to be closely related to the interplay between excitatory corticomotoneurons and inhibitory interneurons. Hyperexcitability is not a static phenomenon but rather shows a pattern of progression in a spatiotemporal aspect. Cortical hyperexcitability may serve as a trigger to the development of anterior horn cell degeneration through a 'dying forward' process. Hyperexcitability appears to develop during the early disease stages and gradually disappears in the advanced stages of the disease, linked to the destruction of corticomotorneuronal pathways. As such, a more precise interpretation of these unique processes may provide new insight regarding the pathophysiology of ALS and its clinical features. Recently developed technologies such as threshold tracking transcranial magnetic stimulation and automated nerve excitability tests have provided some clues about underlying pathophysiological processes linked to hyperexcitability. Additionally, these novel techniques have enabled clinicians to use the specific finding of hyperexcitability as a useful diagnostic biomarker, enabling clarification of various ALS-mimic syndromes, and the prediction of disease development in pre-symptomatic carriers of familial ALS. In terms of nerve excitability tests for peripheral nerves, an increase in persistent Na+ conductances has been identified as a major determinant of peripheral hyperexcitability in ALS, inversely correlated with the survival in ALS. As such, the present Review will focus primarily on the puzzling theory of hyperexcitability in ALS and summarize clinical and pathophysiological implications for current and future ALS research. J Clin Neurol 2013;9:65-74
引用
收藏
页码:65 / 74
页数:10
相关论文
共 97 条
[1]  
[Anonymous], 2001, Muscle Nerve, V24, pS5
[2]  
[Anonymous], ADV NEUROL
[3]   TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis [J].
Arai, Tetsuaki ;
Hasegawa, Masato ;
Akiyama, Haruhiko ;
Ikeda, Kenji ;
Nonaka, Takashi ;
Mori, Hiroshi ;
Mann, David ;
Tsuchiya, Kuniaki ;
Yoshida, Marl ;
Hashizume, Yoshio ;
Oda, Tatsuro .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (03) :602-611
[4]   DIFFERENCES IN EXCITABILITY PROPERTIES OF FDI AND ADM MOTOR AXONS [J].
Bae, Jong Seok ;
Sawai, Setsu ;
Misawa, Sonoko ;
Kanai, Kazuaki ;
Isose, Sagiri ;
Kuwabara, Satoshi .
MUSCLE & NERVE, 2009, 39 (03) :350-354
[5]   How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? [J].
Baloh, Robert H. .
CURRENT OPINION IN NEUROLOGY, 2012, 25 (06) :701-707
[6]  
Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO
[7]  
2-C
[8]   Motor Neuron dysfunction in frontotemporal dementia [J].
Burrell, James R. ;
Kiernan, Matthew C. ;
Vucic, Steve ;
Hodges, John R. .
BRAIN, 2011, 134 :2582-2594
[9]   Pharmacologic reversal of cortical hyperexcitability in patients with ALS [J].
Caramia, MD ;
Palmieri, MG ;
Desiato, MT ;
Iani, C ;
Scalise, A ;
Telera, S ;
Bernardi, G .
NEUROLOGY, 2000, 54 (01) :58-64
[10]   Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis [J].
Cheah, Benjamin C. ;
Lin, Cindy S. Y. ;
Park, Susanna B. ;
Vucic, Steve ;
Krishnan, Arun V. ;
Kiernan, Matthew C. .
CLINICAL NEUROPHYSIOLOGY, 2012, 123 (12) :2460-2467